Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica.

T cells T helper 1 T helper 17 polymyalgia rheumatica ultrasound guided biopsy

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 13 05 2022
accepted: 22 07 2022
entrez: 29 8 2022
pubmed: 30 8 2022
medline: 31 8 2022
Statut: epublish

Résumé

Although polymyalgia rheumatica (PMR) is a very common rheumatic inflammatory disease, current insight into the pathobiology of PMR is limited and largely based on studies in blood. We investigated T helper 1 (T Blood samples were collected from 18 patients with new-onset PMR and 32 healthy controls. Synovial fluid was aspirated from the inflamed shoulder bursae or biceps tendon sheath of 13 patients. Ultrasound-guided biopsies of the subacromial-subdeltoid (SASD) bursa were obtained from 11 patients. T cells were examined by flow cytometry, immunohistochemistry and immunofluorescence staining. Besides an increase of T Although the circulating T

Sections du résumé

Background
Although polymyalgia rheumatica (PMR) is a very common rheumatic inflammatory disease, current insight into the pathobiology of PMR is limited and largely based on studies in blood. We investigated T helper 1 (T
Materials and methods
Blood samples were collected from 18 patients with new-onset PMR and 32 healthy controls. Synovial fluid was aspirated from the inflamed shoulder bursae or biceps tendon sheath of 13 patients. Ultrasound-guided biopsies of the subacromial-subdeltoid (SASD) bursa were obtained from 11 patients. T cells were examined by flow cytometry, immunohistochemistry and immunofluorescence staining.
Results
Besides an increase of T
Conclusion
Although the circulating T

Identifiants

pubmed: 36032100
doi: 10.3389/fimmu.2022.943574
pmc: PMC9402989
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

943574

Informations de copyright

Copyright © 2022 Reitsema, Jiemy, Wekema, Boots, Heeringa, Huitema, Abdulahad, van Sleen, Sandovici, Roozendaal, Diepstra, Kwee, Dasgupta, Brouwer and van der Geest.

Déclaration de conflit d'intérêts

KG reports personal fees from Roche, outside the submitted work. BD reports consulting fees from Roche, Chugai, Sanofi, and sponsorship grants for international meetings and workshops with Roche, Sanofi, AbbVie and GlaxoSmithKline. EB reports personal fees from Roche, outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Rheumatology (Oxford). 2020 Oct 1;59(10):2864-2871
pubmed: 32077962
Rheumatology (Oxford). 2022 Mar 2;61(3):1072-1082
pubmed: 34117743
Medicine (Baltimore). 2014 Jul;93(5):194-201
pubmed: 25181312
Arthritis Rheumatol. 2015 Oct;67(10):2601-10
pubmed: 26097225
Arthritis Rheumatol. 2014 May;66(5):1372-7
pubmed: 24470328
Ann Rheum Dis. 2018 Dec;77(12):1730-1735
pubmed: 30076154
PLoS One. 2013 Nov 01;8(11):e79370
pubmed: 24223933
Circulation. 2010 Feb 23;121(7):906-15
pubmed: 20142449
Ann Rheum Dis. 2015 Dec;74(12):2188-92
pubmed: 26376658
Br J Rheumatol. 1990 Dec;29(6):456-8
pubmed: 2124160
Sci Rep. 2017 Jul 26;7(1):6553
pubmed: 28747747
J Immunol. 2010 Apr 1;184(7):3336-40
pubmed: 20200272
J Allergy Clin Immunol. 2015 Mar;135(3):626-35
pubmed: 25528359
Discov Med. 2019 Feb;27(147):63-77
pubmed: 30825883
BMC Musculoskelet Disord. 2021 Oct 14;22(1):877
pubmed: 34649550
Autoimmun Rev. 2022 Feb;21(2):102995
pubmed: 34798314
Rheumatology (Oxford). 2015 Aug;54(8):1397-402
pubmed: 25724206
Clin Transl Immunology. 2020 Aug 27;9(9):e1164
pubmed: 32884747
J Innate Immun. 2010;2(1):56-65
pubmed: 20375623
J Rheumatol. 2019 Oct;46(10):1388-1393
pubmed: 30709946
Arthritis Res Ther. 2018 Dec 3;20(1):265
pubmed: 30509322
Exp Gerontol. 2014 Dec;60:190-6
pubmed: 25449852
J Orthop Res. 1999 May;17(3):392-7
pubmed: 10376728
Arthritis Res Ther. 2014 Aug 22;16(4):426
pubmed: 25146432
Arthritis Rheumatol. 2014 Jul;66(7):1927-38
pubmed: 24623536
J Anat. 2022 May;240(5):941-958
pubmed: 34865216
Immunology. 2009 Mar;126(3):386-93
pubmed: 18759749
Ann Rheum Dis. 2012 Apr;71(4):484-92
pubmed: 22388996
Rheumatology (Oxford). 2020 Jan 1;59(1):176-184
pubmed: 31292652
Front Med (Lausanne). 2022 Jun 06;9:902155
pubmed: 35733858
Arthritis Rheum. 1996 Jul;39(7):1199-207
pubmed: 8670331
J Leukoc Biol. 2004 Feb;75(2):163-89
pubmed: 14525967
Lancet. 2017 Oct 7;390(10103):1700-1712
pubmed: 28774422
Eur J Immunol. 2009 Aug;39(8):2076-82
pubmed: 19672903
Medicine (Baltimore). 2011 May;90(3):186-193
pubmed: 21512412
J Autoimmun. 2021 Sep;123:102684
pubmed: 34237649
Arthritis Rheum. 1997 Oct;40(10):1873-8
pubmed: 9336424
Arthritis Rheum. 2012 Nov;64(11):3788-98
pubmed: 22833233
J Autoimmun. 2016 Aug;72:73-83
pubmed: 27236507
J Rheumatol. 2019 Dec;46(12):1552-1555
pubmed: 31787593
Exp Gerontol. 2016 Mar;75:24-9
pubmed: 26721376
Front Immunol. 2018 Apr 19;9:752
pubmed: 29725326
Front Immunol. 2019 Aug 22;10:1981
pubmed: 31507597
Arthritis Rheum. 2011 Aug;63(8):2504-15
pubmed: 21381000
Eur J Immunol. 2012 Dec;42(12):3180-8
pubmed: 22965818
Ann Rheum Dis. 2016 Jun;75(6):1177-86
pubmed: 26698852
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
Autoimmun Rev. 2020 Nov;19(11):102670
pubmed: 32942037
Histopathology. 2006 Oct;49(4):358-64
pubmed: 16978198
RMD Open. 2015 Aug 13;1(1):e000100
pubmed: 26535139
Aging Cell. 2015 Oct;14(5):744-53
pubmed: 26010129

Auteurs

Rosanne D Reitsema (RD)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

William F Jiemy (WF)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Lieske Wekema (L)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Annemieke M H Boots (AMH)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Peter Heeringa (P)

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Minke G Huitema (MG)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Wayel H Abdulahad (WH)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Yannick van Sleen (Y)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Maria Sandovici (M)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Caroline Roozendaal (C)

Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Arjan Diepstra (A)

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Thomas Kwee (T)

Medical Imaging Center, Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Bhaskar Dasgupta (B)

Department of Rheumatology, Southend University Hospital, Westcliff-on-Sea, United Kingdom.

Elisabeth Brouwer (E)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Kornelis S M van der Geest (KSM)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH